Amiloride-HCl, which is an oral potassium-sparing diuretic, has been shown to exert anti-tumor and anti-metastasis activities through uPA and the sodium–hydrogen exchanger1 (NHE1), a membrane protein responsible for the low extracellular pH in tumors [141]. This evidence concerns the gene PLAU and neoplasm.